Cara Therapeutics Inc (NASDAQ: CARA) and Vifor Pharma have announced that the U.S Food and Drug Administration (FDA) has approved KORSUVA™ (difelikefalin) to treat moderate to...
Cara Therapeutics Inc. (NASDAQ: CARA) has announced its Q2 2021 financial results and its operational results for the period ending June 30, 2021. Cara didn’t recognize...